My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Eli Lilly (NY:LLY)

1,071.64 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Dec 23, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

99 100 Next >

Jim Cramer Says 'Take A Pass' On This Tech Stock, Won't Go Near Oils ↗

November 05, 2025

Zoom Communications is a good company, Cramer says. Still, he advises, "take a pass." Plus: Viking Therapeutics, Profrac and Altria.

Via Benzinga

Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy ↗

November 05, 2025

The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.

Via The Motley Fool

Eli Lilly And Company Stock Signal: Did Earnings Justify The Rally? ↗

November 05, 2025

A massive earnings beat sent shares rallying, but the latest GLP-1 treatment underperformed, while long-term debt is rising and profit margins are shrinking.

Via Talk Markets

Topics Earnings

Elanco (NYSE:ELAN) Surprises With Q3 Sales

November 05, 2025

Animal health company Elanco (NYSE:ELAN) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 10.4% year on year to $1.14 billion. Guidance for next quarter’s revenue was...

Via StockStory

Eli Lilly And Novo Nordisk Ignite Bullish Retail Frenzy Ahead Of TrumpRx Deals To Slash Prices For Weight-Loss Drugs ↗

November 04, 2025

Via Stocktwits

Novo Nordisk Q3 Preview: Analysts See Profit Drop As Obesity Market Cools, Pfizer Tensions Rise ↗

November 04, 2025

Via Stocktwits

This Company Now Has the World's No. 1 Drug. Should You Invest $1,000? ↗

November 05, 2025

Lilly's GLP-1 drug became the best-selling drug on Earth in the third quarter.

Via The Motley Fool

Can Novo Nordisk’s ‘Attractive’ Fundamentals Outweigh Slowing Wegovy Sales And A $149 Price Cap? ↗

November 05, 2025

Novo Nordisk cut its 2025 profit and sales forecasts as slower GLP-1 growth and pricing pressure hit margins.

Via Stocktwits

Topics Lawsuit

Eli Lilly Stock Sees RS Rating Rise To 77 ↗

November 05, 2025

li Lilly stock saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 70 to 77.

Via Investor's Business Daily

Earnings To Watch: Collegium Pharmaceutical (COLL) Reports Q3 Results Tomorrow

November 04, 2025

Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) will be announcing earnings results this Thursday before market open. Here’s what investors should know.

Via StockStory

Viatris (VTRS) Q3 Earnings Report Preview: What To Look For

November 04, 2025

Medication company Viatris (NASDAQ:VTRS) will be reporting earnings this Thursday before market open. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Amphastar Pharmaceuticals (AMPH) To Report Earnings Tomorrow: Here Is What To Expect

November 04, 2025

Via StockStory

Billionaire Stanley Druckenmiller Dropped Nvidia and Palantir Stock and Is Piling into 2 Stocks Set to Win in One of the Decade's Hottest Growth Markets. ↗

November 04, 2025

It's a great idea to watch the latest moves of this expert investor.

Via The Motley Fool

Topics Artificial Intelligence

AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential

November 04, 2025

The burgeoning fields of cell and gene therapy (CGT) are on the cusp of a profound revolution, driven by the relentless advancements in artificial intelligence. This transformative impact was a central...

Via TokenRing AI

Topics Artificial Intelligence

Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play ↗

November 04, 2025

Via MarketBeat

Eli Lilly, Novo Nordisk Stocks Rise on Reported $149 Obesity Drug Deal with White House ↗

November 04, 2025

Eli Lilly and Company (NYSE:LLY) shares are trading slightly lower on Tuesday after its previous gains following reports indicating the company is close to finalizing a White House agreement to provide...

Via Benzinga

Is Eli Lilly a Millionaire Maker? ↗

November 04, 2025

Eli Lilly has a leading position in a hot new drug category, but there's one notable problem to consider.

Via The Motley Fool

Topics Intellectual Property

Are Wall Street Analysts Predicting Eli Lilly Stock Will Climb or Sink?

November 04, 2025

While the pharma giant Eli Lilly has lagged behind the broader market over the past year, it has outpaced the health care space, and analysts remain strongly bullish on the stock’s prospects.

Via Barchart.com

Elanco (ELAN) To Report Earnings Tomorrow: Here Is What To Expect

November 03, 2025

Animal health company Elanco (NYSE:ELAN) will be reporting earnings this Wednesday before market hours. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Earnings To Watch: Jazz Pharmaceuticals (JAZZ) Reports Q3 Results Tomorrow

November 03, 2025

Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) will be reporting earnings this Wednesday afternoon. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

What To Expect From Royalty Pharma’s (RPRX) Q3 Earnings

November 03, 2025

Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) will be reporting earnings this Wednesday before the bell. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

Hims & Hers Health (HIMS) Surges After Hours on Robust Q3 and Renewed Novo Nordisk (NVO) Wegovy Talks

November 03, 2025

Hims & Hers Health (NYSE: HIMS) became a significant after-hours mover on Monday, November 3, 2025, following the release of its third-quarter 2025 financial results and the pivotal announcement of...

Via MarketMinute

Topics Artificial Intelligence Economy

Stay informed with the top movers within the S&P500 index on Monday. ↗

November 03, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday.

Via Chartmill

What's Up With The Rise In Eli Lilly Stock Today? ↗

November 03, 2025

Eli Lilly shares are trading higher on Monday. The pharmaceutical giant announced a significant European manufacturing expansion.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 03, 2025

Via Benzinga

ELI LILLY & CO (NYSE:LLY): A Dividend Growth Stock with Strong Profitability ↗

November 03, 2025

Discover Eli Lilly (LLY), a dividend stock with a 10+ year payment history, 15.59% average growth, strong profitability, and solid financial health for reliable income.

Via Chartmill

2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon ↗

November 03, 2025

The healthcare industry is chock-full of opportunities for long-term investors.

Via The Motley Fool

Topics Government World Trade

2 Beaten-Down Stocks That Could Be About to Rally ↗

November 03, 2025

It would be best to get in before the rest of the market pounces on these opportunities.

Via The Motley Fool

Prediction: The Next Eli Lilly Might Already Be Trading Under $50 ↗

November 03, 2025

Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.

Via The Motley Fool

What To Expect From Zoetis’s (ZTS) Q3 Earnings

November 02, 2025

Animal health company Zoetis (NYSE:ZTS) will be reporting results this Tuesday morning. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.